repsox and Osteosarcoma

repsox has been researched along with Osteosarcoma* in 1 studies

Other Studies

1 other study(ies) available for repsox and Osteosarcoma

Article	Year
TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway. International journal of oncology, 2021, Volume: 59, Issue:5 Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Pyrazoles; Pyridines; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta	2021

Article

Year

TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway.

International journal of oncology, 2021, Volume: 59, Issue:5

Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Pyrazoles; Pyridines; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta

2021